Related Experiment Video

Updated: Jan 28, 2026

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.4K

Atherosclerosis and Nanomedicine Potential: Current Advances and Future Opportunities

Fan Jiang1, Yunqi Zhu1, Changyang Gong2

  • 1School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

Current Medicinal Chemistry
|March 5, 2019
PubMed

Insights

Nanomedicine offers advanced atherosclerosis diagnosis and treatment by enabling targeted drug delivery and novel therapies. This approach aims to overcome the limitations of conventional treatments for cardiovascular diseases.

Area of Science:

  • Cardiovascular Research
  • Nanomedicine Applications
  • Arterial Disease Therapeutics

Background:

  • Atherosclerosis is a primary cause of global mortality, characterized by arterial wall changes and dyslipidemia.
  • Current treatments, including lipid-regulating and anti-inflammatory therapies, have limited efficacy and side effects.
  • Conventional drug delivery systems are insufficient for managing atherosclerosis progression.

Purpose of the Study:

  • To review the latest nanomedicine strategies for atherosclerosis diagnosis and treatment.
  • To identify potential therapeutic targets in atherosclerosis progression.
  • To explore the development of novel nanoplatforms for atherosclerosis management.

Main Methods:

  • Review of recent advancements in nanomedicine for atherosclerosis.
  • Analysis of nanomedicine-based targeted therapy and controlled drug delivery.
  • Discussion of novel diagnostic modalities and biocompatible scaffolds.

Main Results:

  • Nanomedicine enables targeted drug delivery, improving therapeutic efficacy for atherosclerosis.
  • Novel nanoplatforms offer potential for early diagnosis and effective treatment.
  • Biocompatible nanoscaffolds show promise for multifunctional therapeutic applications.

Conclusions:

  • Nanomedicine represents a significant evolution in atherosclerosis diagnosis and treatment.
  • Targeted therapies and advanced drug delivery systems are key nanomedicine contributions.
  • Further research into nanoplatforms and therapeutic targets can lead to improved cardiovascular disease outcomes.
Keywords:
Atherosclerosiscardiovascular diseasesdiagnosisdrug delivery systemnanomedicinescaffoldstheranosticstreatment.

More Related Videos

Using Generative Art to Convey Past and Future Climate Transitions06:10

Using Generative Art to Convey Past and Future Climate Transitions

Published on: March 31, 2023

1.5K
Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis08:13

Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis

Published on: March 22, 2016

11.0K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
371
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.0K
Electrical Current01:10

Electrical Current

Electrical current is defined as the rate at which charge flows. When there is a large current present, such as that used to run a refrigerator, a large amount of charge moves through the wire in a small amount of time. If the current is small, such as that used to operate a handheld calculator, a small amount of charge moves through the circuit over a long period of time. The SI unit for current is the ampere (A), named for the French physicist André-Marie Ampère (1775–1836).
7.1K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
520
Potential Energy00:52

Potential Energy

The energy stored by a structure and location of matter in space is called potential energy. For instance, raising a kettlebell changes its spatial location and increases its potential energy. Similarly, a stretched rubber band contains potential energy which, under certain conditions, can be converted into other forms of energy, such as kinetic energy.
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
42.7K
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K